These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Migliore F, Zorzi A, Silvano M, Bevilacqua M, Leoni L, Marra MP, Elmaghawry M, Brugnaro L, Dal Lin C, Bauce B, Rigato I, Tarantini G, Basso C, Buja G, Thiene G, Iliceto S, Corrado D. Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):167-76. PubMed ID: 23392584 [Abstract] [Full Text] [Related]
29. Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study. Santangeli P, Dello Russo A, Pieroni M, Casella M, Di Biase L, Burkhardt JD, Sanchez J, Lakkireddy D, Carbucicchio C, Zucchetti M, Pelargonio G, Themistoclakis S, Camporeale A, Rossillo A, Beheiry S, Hongo R, Bellocci F, Tondo C, Natale A. Heart Rhythm; 2012 Aug; 9(8):1200-6. PubMed ID: 22465294 [Abstract] [Full Text] [Related]
30. Prognostic value of QRS fragmentation in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Peters S, Truemmel M, Koehler B. J Cardiovasc Med (Hagerstown); 2012 May; 13(5):295-8. PubMed ID: 22450866 [Abstract] [Full Text] [Related]
32. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. Gandjbakhch E, Laredo M, Berruezo A, Gourraud JB, Sellal JM, Martins R, Sacher F, Pison L, Pruvot E, Jáuregui B, Frontera A, Kumar S, Wong T, DellaBella P, Maury P. Europace; 2021 Sep 08; 23(9):1428-1436. PubMed ID: 34427302 [Abstract] [Full Text] [Related]
34. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy. Protonotarios A, Anastasakis A, Panagiotakos DB, Antoniades L, Syrris P, Vouliotis A, Stefanadis C, Tsatsopoulou A, McKenna WJ, Protonotarios N. Europace; 2016 Apr 08; 18(4):610-6. PubMed ID: 25825460 [Abstract] [Full Text] [Related]
35. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry. Migliore F, Viani S, Bongiorni MG, Zorzi A, Silvetti MS, Francia P, D'Onofrio A, De Franceschi P, Sala S, Donzelli S, Ricciardi G, Menardi E, Giammaria M, La Greca C, Bauce B, Rigato I, Iliceto S, Bertaglia E, Diemberger I, Corrado D. Int J Cardiol; 2019 Apr 01; 280():74-79. PubMed ID: 30661851 [Abstract] [Full Text] [Related]
39. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy. Roudijk RW, Verheul L, Bosman LP, Bourfiss M, Breur JMPJ, Slieker MG, Blank AC, Dooijes D, van der Heijden JF, van den Heuvel F, Clur SA, Udink Ten Cate FEA, van den Berg MP, Wilde AAM, Asselbergs FW, Peter van Tintelen J, Te Riele ASJM. JACC Clin Electrophysiol; 2022 Mar 01; 8(3):306-318. PubMed ID: 35331425 [Abstract] [Full Text] [Related]
40. Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Carrick RT, Te Riele ASJM, Gasperetti A, Bosman L, Muller SA, Pendleton C, Tichnell C, Murray B, Yap SC, van den Berg MP, Wilde A, Zeppenfeld K, Hays A, Zimmerman SL, Tandri H, Cadrin-Tourigny J, van Tintelen P, Calkins H, James CA, Wu KC. Circ Arrhythm Electrophysiol; 2022 Nov 01; 15(11):e011207. PubMed ID: 36315818 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]